|Bid||600.44 x 800|
|Ask||600.85 x 1000|
|Day's range||597.86 - 603.91|
|52-week range||497.83 - 672.34|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||27.91|
|Earnings date||27 Apr 2022 - 02 May 2022|
|Forward dividend & yield||1.20 (0.20%)|
|Ex-dividend date||14 Sept 2022|
|1y target est||659.53|
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.
Thermo Fisher's (TMO) novel Applied Biosystems HIV-1 Genotyping Kit will aid in the global efforts to monitor the evolution of HIV.